#TCT2016

1 stories · following the connections

Business

Amaranth Medical 9-Months Clinical and Imaging Results of the FORTITUDE Sirolimus-Eluting Bioresorbable Scaffold Presented at TCT

By Nasdaq OMXOct 31, 2016, 4:30 PM UTC